kw.\*:(%22Syst%C3%A8me HLA-DR%22)
Results 1 to 25 of 23595
Selection :
INFLUENCE DE L'ASSOCIATION C3b-TOXINE TETANIQUE SUR LA PRODUCTION DE PEPTIDES IMMUNOGENIQUES = INFLUENCE OF C3b-TETANUS TOXIN ASSOCIATION ON IMMUNOGENICS PEPTIDE PRODUCTIONSerra, Vincent; Gabert, Francoise.1998, 161 p.Thesis
Genetic variants of complement component 3(C3) in DR4 positive and DR4 negative rheumatoid arthritisTHOMSON, W; DYER, P. A; SANDERS, P. A et al.Annals of the rheumatic diseases. 1986, Vol 45, Num 4, pp 269-271, issn 0003-4967Article
STRONG ASSOCIATION OF IDIOPATHIC MEMBRANOUS NEPHROPATHY (IMN) WITH HLA-DR3 AND MT-2 WITHOUT INVOLVEMENT OF HLA-B18 AND NO ASSOCIATION TO BFF1MUELLER GA; MUELLER C; LIEBAU G et al.1981; TISSUE ANTIGENS; ISSN 0001-2815; DNK; DA. 1981; VOL. 17; NO 3; PP. 332-337; BIBL. 25 REF.Article
Linkage disequilibrium between the HLA-B14 subdivisions and HLA-A, DR and properdin factor B allelesDARKE, C.Tissue antigens. 1984, Vol 23, Num 1, pp 68-71, issn 0001-2815Article
A STUDY OF GENETIC MARKERS IN A FAMILY WITH POLYENDOCRINE DISEASEBRUETON MJ; CHAPEL HM; MACKINTOSH LP et al.1980; TISSUE ANTIGENS; DNK; DA. 1980; VOL. 15; NO 1; PP. 101-103; BIBL. 4 REF.Article
Definition of a new DR2 short associated HLA-D specificity with the ninth histocompatibility workshop reagentsCOHEN, N; AMAR, A; BRAUTBAR, C et al.Tissue antigens. 1984, Vol 24, Num 3, pp 184-186, issn 0001-2815Article
Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Japanese patientsTAKEUCHI, F; MIMORI, A; MATSUTA, K et al.Arthritis and rheumatism. 1989, Vol 32, Num 6, pp 691-698, issn 0004-3591Article
Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5KRATZ, L. E; BOUGHMAN, J. A; NEEDLEMAN, B. W et al.Disease markers. 1989, Vol 7, Num 4, pp 209-213, issn 0278-0240, 5 p.Article
The prevalence of HLA-DR 4 and HLA-DR 3 in healthy persons with rheumatoid factorGRAN, J. T; HUSBY, G; THORSBY, E et al.Scandinavian journal of rheumatology. 1985, Vol 14, Num 1, pp 79-82, issn 0300-9742Article
HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritisSINGAL, D. R; REID, B; KASSAM, Y. B et al.Lancet (British edition). 1987, Vol 2, Num 8568, pp 1118-1120, issn 0140-6736Article
Association between susceptibility to pre-eclampsia within families and HLA DR4KILPATRICK, D. C; GIBSON, F; LISTON, W. A et al.Lancet (British edition). 1989, Vol 2, Num 8671, pp 1063-1065, issn 0140-6736, 3 p.Article
Heterogeneity of HLA-DRS: definition of two subtypes by the primed lymphocyte testSINGAL, D. P; D'SOUZA, M; BUTLER, L et al.Tissue antigens. 1985, Vol 26, Num 3, pp 172-178, issn 0001-2815Article
Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprineJournal of neurology, neurosurgery and psychiatry. 1988, Vol 51, Num 3, pp 412-415, issn 0022-3050Article
Insulin autoimmune syndrome and LHA-DR4SPINAS, G. A; KELLER, U.Lancet (British edition). 1992, Vol 339, Num 8808, issn 0140-6736, p. 1549Article
Class II MHC antigen (HLA-DR3) predisposes to sarcoid arthritisKRAUSE, A; GOEBEL, K. M.Journal of clinical & laboratory immunology. 1987, Vol 24, Num 1, pp 25-27, issn 0141-2760Article
Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatosesLAMPERT, I. A.Clinical and experimental immunology (Print). 1984, Vol 57, Num 1, pp 93-100, issn 0009-9104Article
Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potencySZEWCZUK, Zbigniew; BIERNAT, Monika; DYBA, Marcin et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 2, pp 207-215, issn 0196-9781, 9 p.Article
HLA-DR-antigen bearing keratinocytes in various dermatologic disordersSMOLLE, J.Acta dermato-venereologica. 1985, Vol 65, Num 1, pp 9-13, issn 0001-5555Article
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in diseaseVOLC-PLATZER, B; MAJDIC, O; KNAPP, W et al.The Journal of experimental medicine. 1984, Vol 159, Num 6, pp 1784-1789, issn 0022-1007Article
Study of HLA-DR2 associated HLA-Dw/LD specificitiesREINSMOEN, N. L; ZULAY LAYRISSE; BETUEL, H et al.Human immunology. 1984, Vol 11, Num 2, pp 105-115, issn 0198-8859Article
Identification of HLA-DRw52 associated antigens using HLA class II allogenotypingSAVAGE, D. A; BIDWELL, J. L; CULLEN, C et al.Tissue antigens. 1988, Vol 32, Num 5, pp 278-285, issn 0001-2815Article
HLA DR4 and giant cell arteritisBIGNON, J. D; BARRIER, J; SOULILLOU, J. P et al.Tissue antigens. 1984, Vol 24, Num 1, pp 60-62, issn 0001-2815Article
The HLA-DR4 family of haplotypes consists of a series of distinct DR and DS moleculesNEPOM, G. T; NEPOM, B. S; ANTONELLI, P et al.The Journal of experimental medicine. 1984, Vol 159, Num 2, pp 394-404, issn 0022-1007Article
The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK : HLA DRB1*12 and its associated DRB1*12/DQB1*0301 /04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB1*0301/04 and its associated DRB1*0301/04/DQB1*0201/02/03 haplotype protects from vulval lichen sclerosusGAO, Xing-Hua; BARNARDO, Martin C. M. N; WINSEY, Samantha et al.Journal of investigative dermatology. 2005, Vol 125, Num 5, pp 895-899, issn 0022-202X, 5 p.Article
Differential expression of Ia molecules by human monocytesGONWA, T. A; STOBO, J. D.The Journal of clinical investigation. 1984, Vol 74, Num 3, pp 859-866, issn 0021-9738Article